MTOR kinase inhibitor sensitizes T-cell lymphoblastic leukemia for chemotherapy-induced DNA damage via suppressing FANCD2 expression

F. Guo, J. Li, S. Zhang, W. Du, S. Amarachintha, J. Sipple, J. Phelan, H. L. Grimes, Y. Zheng, Q. Pang

Research output: Contribution to journal › Letter › peer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'MTOR kinase inhibitor sensitizes T-cell lymphoblastic leukemia for chemotherapy-induced DNA damage via suppressing FANCD2 expression'. Together they form a unique fingerprint.